Determinants of racial/ethnic colorectal cancer screening disparities
- PMID: 18574089
- DOI: 10.1001/archinte.168.12.1317
Determinants of racial/ethnic colorectal cancer screening disparities
Abstract
Background: The contributions of demographic, socioeconomic, access, language, and nativity factors to racial/ethnic colorectal cancer (CRC) screening disparities are uncertain.
Methods: Using linked data from 22 973 respondents to the 2001-2005 Medical Expenditure Panel Survey and the 2000-2004 National Health Interview Survey, we modeled disparities in CRC screening (fecal occult blood testing [FOBT], endoscopy, and combined FOBT and endoscopy) between non-Hispanic whites and Asians, blacks, and Hispanics, sequentially adjusting for demographics, socioeconomic status, clinical and access variables, and race/ethnicity-related variables (language spoken at home and nativity).
Results: With demographic adjustment, minorities reported less CRC screening (all measures) than non-Hispanic whites. Disparities were largest for combined screening in Asians (adjusted odds ratio [AOR], 0.40; 95% confidence interval [CI], 0.32-0.49) and Hispanics (AOR, 0.43; 95% CI, 0.39-0.48) and for endoscopic screening in Asians (AOR, 0.41; 95% CI, 0.33-0.50) and Hispanics (AOR, 0.43; 95% CI, 0.38-0.48). With full adjustment, all Hispanic/non-Hispanic white disparities and black/non-Hispanic white FOBT disparities were eliminated, whereas Asian/non-Hispanic white disparities remained significant (FOBT: AOR, 0.72 [95% CI, 0.52-1.00]; endoscopic screening: AOR, 0.63 [95% CI, 0.49-0.81]; and combined screening: AOR, 0.66 [95% CI, 0.52-0.84]).
Conclusions: Determinants of racial/ethnic CRC screening disparities vary among minority groups, suggesting the need for different interventions to mitigate those disparities. Whereas socioeconomic, access, and language barriers seem to drive the CRC screening disparities experienced by blacks and Hispanics, additional factors may exacerbate the disparities experienced by Asians.
Similar articles
-
Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.Am J Prev Med. 2014 Mar;46(3):228-36. doi: 10.1016/j.amepre.2013.10.023. Am J Prev Med. 2014. PMID: 24512861
-
Influence of patient-provider communication on colorectal cancer screening.Med Care. 2008 Jul;46(7):738-45. doi: 10.1097/MLR.0b013e318178935a. Med Care. 2008. PMID: 18580394
-
Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005.Am J Prev Med. 2008 Sep;35(3):185-93. doi: 10.1016/j.amepre.2008.05.021. Epub 2008 Jul 10. Am J Prev Med. 2008. PMID: 18617355
-
Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States.Cancer Causes Control. 2008 May;19(4):339-59. doi: 10.1007/s10552-007-9100-y. Epub 2007 Dec 18. Cancer Causes Control. 2008. PMID: 18085415 Review.
-
Racial and ethnic differences in reproductive potential across the life cycle.Fertil Steril. 2010 Feb;93(3):681-90. doi: 10.1016/j.fertnstert.2009.10.047. Epub 2009 Nov 25. Fertil Steril. 2010. PMID: 19939362 Review.
Cited by
-
Race/ethnicity, insurance, income and access to care: the influence of health status.Int J Equity Health. 2013 May 11;12:29. doi: 10.1186/1475-9276-12-29. Int J Equity Health. 2013. PMID: 23663514 Free PMC article.
-
Obesity and Cancer Screening according to Race and Gender.J Obes. 2011;2011:218250. doi: 10.1155/2011/218250. Epub 2011 Dec 15. J Obes. 2011. PMID: 22220270 Free PMC article.
-
Predicting breast and colon cancer screening among English-as-a-second-language older Chinese immigrant women to Canada.J Cancer Educ. 2011 Mar;26(1):161-9. doi: 10.1007/s13187-010-0141-7. J Cancer Educ. 2011. PMID: 20625870
-
Prevalence of colon polyps detected by colonoscopy screening of asymptomatic Hispanic patients.Dig Dis Sci. 2012 Feb;57(2):481-8. doi: 10.1007/s10620-011-1898-1. Epub 2011 Sep 15. Dig Dis Sci. 2012. PMID: 21918852 Free PMC article.
-
Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement.Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):811-7. doi: 10.1158/1055-9965.EPI-09-0963. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21546366 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical